Skip to main content
. Author manuscript; available in PMC: 2022 Nov 17.
Published in final edited form as: Lancet. 2022 Nov 4:S0140-6736(22)02074-8. doi: 10.1016/S0140-6736(22)02074-8

Figure 2. Effect of SGLT2 inhibitors on KIDNEY DISEASE PROGRESSION, by presumed primary kidney disease (CKD trials only).

Figure 2